Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation

https://doi.org/10.20996/1819-6446-2020-10-21

Full Text:

Abstract

The purpose of this review was to present modern studies that examine the relationship of physical activity and risk of atrial fibrillation (AF) development and the impact of cardiac rehabilitation programs in patients with all forms of AF. Data of 52 Russian and foreign scientific sources published in 1998- 2020 were presented. In our study, 48 patients with paroxysmal AF after radiofrequency ablation (RFA) were randomly assigned to a physical rehabilitation/standard therapy or control (standard therapy) group. Aerobic physical training was conducted for 6 months 3 times a week. AF is one of the most common cardiac arrhythmias. Despite modern advances, results of treatment of this disease are far from optimal. Many problems of patients with AF can be addressed through enrolment in multidisciplinary cardiac rehabilitation programs. But this question remains open. This is mainly due to the complexity of selection of physical rehabilitation program for patients with AF. It is known that physical activity can trigger an episode of AF. In the following review article, the approaches to functional capacity assessment of patient with AF are described, recommendations for prescribing safe exercise training to achieve a therapeutic effect are presented. Various aspects of the effects of physical rehabilitation are discussed, including its impact on cardiovascular risk factors, influence on atrial remodeling processes and associated biomarkers, prevention of AF progression and occurrence of cardiovascular complications. Results of our own research indicate effectiveness of physical training in patients with AF after RFA: increase in exercise duration by 18.6% (p<0.001) and load by 24.8% (p<0.01) during exercise test, increase in level of everyday physical activity by 23.8% (p=0.001); left atrium dimensions remain stable comparing with control group. That was combined with a decrease of post ablation atrial arrhythmias: after 6 months, they were registered in 4.5% of trained patients vs 17.4% of control group patients (p<0.01). Steady growth in the number of patients with AF and catheter ablation procedures around the world dictates the need for organization of multi-purpose medical rehabilitation.

About the Authors

M. G. Bubnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Marina G. Bubnova – MD, PhD, Professor, Head of Department of Rehabilitation and Secondary Prevention for Cardiovascular Disease

Petroverigsky per. 10, Moscow, 101990



D. M. Aronov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

David M. Aronov – MD, PhD, Professor, Chief Researcher, Department of Rehabilitation and Secondary Prevention for Cardiovascular Disease

Petroverigsky per. 10, Moscow, 101990



References

1. Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI:10.1093/eurheartj/ehw210.

2. Calkins H., Hindricks G., Cappato R., et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018;20:e1-e160. DOI:10.1093/europace/eux274.

3. Haegeli L.M., Calkins H.. Catheter ablation of atrial fibrillation: an update. Eur. Heart J. 2014;35: 2454- 59. DOI:10.1093/eurheartj/ehu291.

4. Bottoni N., Bertaglia E., Donateo P., et. al. Long-term clinical outcome of patients who failed catheter ablation of atrial fibrillation. Europace. 2015;17:403-38. DOI:10.1093/europace/euu229.

5. Reichlin T., Lockwood S.J., Conrad M.J., et al. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation. J Interv Card Electrophysiol. 2016;47(1):69-74. DOI:10.1007/s10840.016-0125-6.

6. Harada M., VanWagoner D.R., Nattel S.. Role of inflammation in atrial fibrillation pathophysiology and management. Circulation J. 2015;79(3):495-502. DOI:10.1253/circj.CJ-15-0138.

7. Lau D.H., Schotten U., Mahajan R., et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573-81. DOI:10.1093/eurheartj/ehv375.

8. Sohns C., Marrouche N.F. Atrial fibrillation and cardiac fibrosis. Eur Heart J. 2020;41:1123-31. DOI:10.1093/eurheartj/ehz786.

9. Kotecha D., Günter B., Camm A.J., et al. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRAConsensus Conference. Europace. 2018;20:395-407. DOI:10.1093/europace/eux318.

10. Heidbüchela H., Panhuyzen-Goedkoopb N., Corradod D., et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Position Paper. Eur J Cardiovascular Prevention and Rehabilitation. 2006;13:475-84.

11. Keteyian S.J., Ehrman J.K., Fuller B., Pack Q.R. Exercise Testing and Exercise Rehabilitation for Patients With Atrial Fibrillation. J Cardiopulm Rehabil Prev. 2019;39:65-72. DOI: 10.1097/HCR.0000000000000423.

12. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 9 th ed. Baltimor: Wolters Kluwer, Lippincott Williams & Wilkins; 2014.

13. Fletcher G.F., Ades P.A., Kligfield P., et al. Exercise standards for testing and training. A Scientific Statement from the American Heart Association. Circulation. 2013;128:873-934. DOI:10.1161/CIR.0b013e31829b5b44.

14. Aronov D.M., Lupanov V.P. Cardiac Functional Test. Moscow: MEDpress-inform; 2002. (In Russ.)

15. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7. DOI:10.1164/ajrccm.166.1.at1102.

16. Karjalainen J., Kujala U.M., Kaprio J., et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998;313:1784-85.

17. Morseth B., Graff-Iversen S., Jacobsen B.K., et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study. Eur Heart J. 2016;37:2307-13. DOI:10.1093/eurheartj/ehw059.

18. Seccia T.M., Caló L.A. Is exercise becoming a danger for our health? The complex relationship between exercise and atrial fibrillation. Eur J Prev Cardiol. 2018;25(6):621-3. DOI:10.1177/2047487318762445.

19. Calvo N., Ramos P., Montserrat S., et al. Emerging risk factors and the dose–response relationship between physical activity and lone atrial fibrillation: a prospective case–control study. Europace. 2015;18:57-63. DOI:10.1093/europace/euv216.

20. Skielboe A.K., Marott J.L., Dixen U., et al. Occupational physical activity, but not leisure-time physical activity increases the risk of atrial fibrillation: The Copenhagen City Heart Study. Eur J Prev Cardiol. 2016;23:1883-93. DOI:10.1177/2047487316655464.

21. Drca N., Wolk A., Jensen-Urstad M., Larsson S.C. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100:1037-42. DOI:10.1136/heartjnl-2013-305304.

22. Van Gelder I.C., Hobbelt A.H., Brugemann J., Rienstra M. Time to implement fitness and reduction of fatness in atrial fibrillation therapy. Europace. 2017;19(4):513-4. DOI:10.1093/europace/euw287.

23. Zhu W., Shen Y., Zhou Q., et al. Association of Physical Fitness With the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Clin. Cardiol. 2016;39(7):421-8. DOI:10.1002/clc.22552.

24. Ricci C., Gervasi F., Gaeta M., et al. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018;25(8):857-66. DOI:10.1177/2047487318768026.

25. Mozaffarian D., Furberg C.D., Psaty B.M., et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118:800-7. DOI:10.1161/CIRCULATIONAHA.108.785626.

26. Azarbal F., Stefanick M.L., Salmoirago-Blotcher E., et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc. 2014;3:e001127. DOI:10.1161/JAMA.114.001127.

27. Abed H.S., Wittert G.A., Leong D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050-60. DOI:10.1001/jama.2013.280521.

28. Pathak R.K., Middeldorp M.E., Lau D.H., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222-31. DOI:10.1016/j.jacc.2014.09.028.

29. Pathak R.K., Elliott A., Middeldorp M.E., et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol. 2015;66(9):985-96. DOI:10.1016/j.jacc.2015.06.488.

30. Rienstra M., Hobbelt A.H., Alings M., et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE3 trial. Eur Heart J. 2018; 39:2987-96. DOI:10.1093/eurheartj/ehx739.

31. Channon K.M. Exercise and cardiovascular health: new routes to reapmore rewards. Cardiovascular Research. 2020;116:e56–e8. DOI:10.1093/cvr/cvz264.

32. Elliott A.D., Mahajan R., Pathak R.K., et al. Exercise Training and Atrial Fibrillation Further Evidence for the Importance of Lifestyle Change. Circulation. 2016;133:457-9. DOI:10.1161/CIRCULATIONAHA.115.020800.

33. Giacomantonio N.B., Bredin S.S., Foulds H.J., Warburton DE. A Systematic Review of the Health Benefits of Exercise Rehabilitation in Persons Living With Atrial Fibrillation. Can J Cardiol. 2013;29(4):483-91. DOI:10.1016/j.cjca.2012.07.003.

34. Reed J.L., Terada T., Chirico D., et. al. The Effects of Cardiac Rehabilitation in Patients With Atrial Fibrillation: A Systematic Review. Canadian Journal of Cardiology. 2018;34:S284-S95. DOI:10.1016/j.cjca.2018.07.014.

35. Risom S.S., Zwisler A.D., Johansen P.P., et al. Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev. 2017;2:CD011197. DOI:10.1002/14651858.CD011197.pub2.

36. Osbak P.S., Mourier M., Henriksen J.H., et al. Effect of physical exercise training on muscle strength and body composition, and their association with functional capacity and quality of life in patients with atrial fibrillation: a randomized controlled trial. J. Rehabil Med. 2012;44:975-9. DOI:10.2340/16501977-1039.

37. Luo N., Merrill P., Parikh K.S., et al. Exercise training in patients with chronic heart failure and atrial fibrillation. J Am Coll Cardiol. 2017;69:1683-91. DOI:10.1016/j.jacc.2017.01.032.

38. Myers J., McAuley P., Lavie C.J., et al. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis. 2015;57:306-14. DOI:10.1016/j.pcad.2014.09.011.

39. Malmo V., Nes B.M., Amundsen B.H., et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133:466-73. DOI:10.1161/CIRCULATIONAHA.115.01820.

40. Liu X., Guo N., Zhu W., et al. Resting heart rate and the risk of atrial fibrillation. Int. Heart J. 2019;60(4):805-11. DOI: 10.1536/ihj.18-470.

41. Proietti M., Boriani G., Laroche C., et al. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Europace. 2017;19(4):535-43. DOI:10.1093/europace/euw150.

42. Al Harbi M., Giacomantonio N.B., Carter L., et al. The impact of cardiac rehabilitation on atrial fibrillation clinical outcomes. Can J Cardiol. 2016; 32 (suppl 1): S187. DOI:1016/j.cjca.2026.07.294.

43. Younis A., Shaviv E., Nof E., et al. The role and outcome of cardiac rehabilitation in patients with atrial fi brillation. Clin Cardiol. 2018;41:1170-6. DOI: 10.1002/clc.23001.

44. Risom S.S., Zwisler A.D., Rasmussen T.B., et al. Cardiac rehabilitation versus usual care for patients treated with catheter ablation for atrial fibrillation: results of the randomized CopenHeartRFA trial. Am Heart J. 2016;181:120-9. DOI: 10.1016/j.ahj.2016.08.013.

45. Wagner M.K., Zwisler A.D.O., Risom S.S., et al. Sex differences in health status and rehabilitation outcomes in patients with atrial fibrillation treated with ablation: results from the CopenHeartRFA trial. Eur J Cardiovasc Nurs. 2018;17:123-35. DOI:10/1177/1474515117720326.

46. Risom S.S., Lind J., McCabe P.J., Berg S.K. Patient perspectives of participating in the cardiac CopenHeartRFA rehabilitation program for patients treated with ablation for atrial fibrillation. J Multidisciplinary Healthcare. 2018;11;167-74. DOI:10.2147/JMDH.S152823.

47. Sang C.H., Chen K., Pang X.F., et al. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2013;36(1):40-5. DOI:10.1002/clc.22039.

48. Aliot E., Botto G.L., Crijns H.J., Kirchhof P. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Europace. 2014;16:787-96. DOI:10.1093/europace/eut369.

49. Bubnova M.G., Aronov D.M., Makhinova M.M. Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects. Cardiosomatics. 2015;6(3):38-47 (In Russ.)

50. Watanabe H., Tanabe N., Yagihara N., et al. Association between lipid profile and risk of atrial fibrillation. Circ J. 2011;75(12):2767-74. DOI:10.1253/circj.CJ-11-0780.

51. Brandes A., Smit M.D., Nguyen B.O., et al. Risk Factor Management in Atrial Fibrillation. Arrhythmia & electrophysiology review. 2018;7(2):118-27. DOI:10.15420/aer.2018.18.2.

52. Hijazi Z., Oldgren J., Siegbahn A., et al. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J. 2013; 34: 1475-80. DOI:10.1093/eurheartj/eht024.


For citation:


Bubnova M.G., Aronov D.M. Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation. Rational Pharmacotherapy in Cardiology. 2020;16(5):804-814. (In Russ.) https://doi.org/10.20996/1819-6446-2020-10-21

Views: 48


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)